Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Is semaglutide a target therapy for acquired hypothalamic obesity? | Pepdox

Home
Search
PMID 39212830

Is semaglutide a target therapy for acquired hypothalamic obesity?

Pituitary2024PMID: 39212830

View on PubMed DOI: 10.1007/s11102-024-01443-7

Authors

Prodam, Flavia

Keywords

CraniopharyngiomaGLP-1, treatmentHypothalamusObesity